Professional Experience
Dr. Kristensen has built a strong clinical reputation through his work at Aarhus University Hospital and his involvement in oncology research and professional organizations.
- Current Positions:
- Registrar at the Department of Clinical Medicine, Aarhus University
- Medical Doctor at the Department of Oncology, Aarhus University Hospital
- Previous Roles:
- Clinical oncologist in training at Aarhus University Hospital
- Member of the yESTRO committee for professional development in radiotherapy and oncology
Academic Contributions
Dr. Kristensen actively contributes to academic research and education, focusing on improving treatment outcomes in oncology.
- Research Focus: Tumor biology and radiosensitivity in head and neck cancers
- PhD Thesis: High-dose failure and radiosensitivity in head and neck cancer
- Publications:
- Late dysphagia after changes in high-dose clinical tumour volume margin for head and neck cancer patients (Acta Oncologica, 2025)
- A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure analyses outcomes in head and neck squamous cell carcinoma (Radiotherapy and Oncology, 2025)
- High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma – A DAHANCA 19 study (Clinical and Translational Radiation Oncology, 2024)
Areas of Expertise
Dr. Kristensen’s clinical expertise centers on the diagnosis and treatment of head and neck cancers, with a patient-focused approach.
- Head and Neck Cancer: Specializing in squamous cell carcinoma
- Radiation Therapy: Expertise in high-dose radiotherapy protocols
- Oncology Research: Focused on radiosensitivity and tumor biology
Publications and Research
Dr. Kristensen has contributed to numerous peer-reviewed studies that advance the understanding of head and neck cancers.
- Late dysphagia after changes in high-dose clinical tumour volume margin for head and neck cancer patients (Acta Oncologica, 2025)
- A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure analyses outcomes in head and neck squamous cell carcinoma (Radiotherapy and Oncology, 2025)
- High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma – A DAHANCA 19 study (Clinical and Translational Radiation Oncology, 2024)
These studies focus on improving treatment strategies and understanding tumor behavior to enhance patient outcomes.
Patient Care Philosophy
Dr. Kristensen emphasizes compassionate care and patient education as the core of his clinical practice.
- Communication: Clear and empathetic communication with patients
- Patient Education: Ensuring patients understand their conditions and treatment options
- International Patients: Available for online pre-consultations
- Cultural Sensitivity: Personalized care respecting cultural differences
Professional Affiliations
Dr. Kristensen is actively involved in professional organizations that advance oncology research and clinical practice.
- Member of the European Society for Radiotherapy and Oncology (ESTRO) and the yESTRO Committee
- Member of the European Head and Neck Society (EHNS)
- Licensed medical doctor in Denmark with board certification in oncology
FAQs
Common questions about Dr. Kristensen’s practice and patient care.
- Is Dr. Morten Horsholt Kristensen board-certified?
- Yes, he is a licensed medical doctor in Denmark with board certification in oncology.
- What types of surgeries does he perform?
- Dr. Kristensen specializes in radiation therapy for head and neck cancers and does not perform surgeries.
- Does he treat international patients?
- Yes, he is available for online pre-consultations with international patients.
- How long is the typical hospital stay?
- The length of hospital stay varies depending on the treatment plan, tailored to each patient’s needs.
- What languages does he speak?
- Dr. Kristensen is fluent in Danish and English, facilitating communication with a broad range of patients.
